SCHEMBL29613199

SCHEMBL29613199

Cc1cc(CO)c(C)cc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.42
ALDH1A1 P00352 3/20 0.38
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP7 P55210 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HPGD P15428 2/20 0.32
PKM P14618 1/20 0.31
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
PGK1 P00558 1/20 0.31
PGK2 P07205 1/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17244912 1.00 SHBG (0.42) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL14924927 0.91 SHBG (0.42) SHBGALDH1A1NPSR1RAB9ANPC1
SCHEMBL24698730 0.88 SHBG (0.39) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL31413681 0.88 SHBG (0.39) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL6828121 0.86 SHBG (0.38) SHBGALDH1A1ALOX15RAB9ASMN1; SMN2
SCHEMBL1318936 0.86 SHBG (0.42) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL5097086 0.84 SHBG (0.52) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL3958466 0.83 SHBG (0.39) SHBGALDH1A1NPSR1CYP1A2ALOX15
SCHEMBL2472814 0.81 ALDH1A1 (0.38) ALDH1A1NPSR1CYP1A2ALOX15CASP7
SCHEMBL22128456 0.80 SHBG (0.34) SHBGALDH1A1CYP1A2ALOX15CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116615414-A Substituted 6, 7-dihydro-5H-benzo [7] rotaline compounds and derivatives thereof, method for the production and therapeutic use thereof 赛诺菲 2023-08-18 CN disclosed
EP-3265453-B1 NEW PYRIDINONES AND ISOQUINOLINONES AS INHIBITORS OF THE BROMODOMAIN BRD9 BOEHRINGER INGELHEIM INT (DE) 2022-06-29 EP disclosed
US-11319318-B2 Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319318-B2 Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9 BRD9, BRD1, BRD2 SHBG 4322/4885ALDH1A1 2461/4885NPSR1 2692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.